 | • レポートコード：MRC2211A094 • 出版社/出版日：Transparency Market Research / 2022年9月 • レポート形態：英文、PDF、201ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| トレンスペアレンシーマーケットリサーチ社の当調査レポートでは、世界のラベルフリーアレイシステム市場を総合的に調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場見通し、技術別（表面プラズモン共鳴、マイクロカンチレバー、走査型ケルビンナノプローブ、エンタルピーアレイ、その他）分析、用途別（創薬、生体分子相互作用、疾患バイオマーカー検出、その他）分析、エンドユーザー別（受託研究機関、学術・研究機関、製薬＆バイオテクノロジー産業、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などの内容を掲載しています。なお、当書には、GE Healthcare、Attana AB、Agilent Technologies, Inc.、Danaher Corporation、F. Hoffmann-La Roche AG、Bio-Rad Laboratories、GWC Technologies、PerkinElmer, Inc.,、BiOptix, Inc.などの企業情報が含まれています。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場見通し ・世界のラベルフリーアレイシステム市場規模：技術別 - 表面プラズモン共鳴技術の市場規模 - マイクロカンチレバー技術の市場規模 - 走査型ケルビンナノプローブ技術の市場規模 - エンタルピーアレイ技術の市場規模 - その他技術の市場規模 ・世界のラベルフリーアレイシステム市場規模：用途別 - 創薬における市場規模 - 生体分子相互作用における市場規模 - 疾患バイオマーカー検出における市場規模 - その他用途における市場規模 ・世界のラベルフリーアレイシステム市場規模：エンドユーザー別 - 受託研究機関における市場規模 - 学術・研究機関における市場規模 - 製薬＆バイオテクノロジー産業における市場規模 - その他エンドユーザーにおける市場規模 ・世界のラベルフリーアレイシステム市場規模：地域別 - 北米のラベルフリーアレイシステム市場規模 - ヨーロッパのラベルフリーアレイシステム市場規模 - アジア太平洋のラベルフリーアレイシステム市場規模 - 中南米のラベルフリーアレイシステム市場規模 - 中東・アフリカのラベルフリーアレイシステム市場規模 ・競争状況 |
Label-free Array Systems Market – Scope of Report
TMR’s report on the global label-free array systems market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global label-free array systems market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global label-free array systems market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the label-free array systems market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global label-free array systems market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global label-free array systems market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global label-free array systems market.
The report delves into the competitive landscape of the global label-free array systems market. Key players operating in the global label-free array systems market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global label-free array systems market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market label-free array systems.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Label-free Array Systems Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Label-free Array Systems Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Key Mergers & Acquisitions
5.2. Technological Advancements
5.3. Healthcare Industry Overview
5.4. Regulatory Scenario, by Region/globally
6. Global Label-free Array Systems Market Analysis and Forecast, by Technique
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Surface Plasmon Resonance
6.3.2. Microcantilever
6.3.3. Scanning Kelvin Nanoprobe
6.3.4. Enthalpy Array
6.3.5. Atomic Force Microscopy
6.3.6. Electrochemical Impedance Spectroscopy
6.3.7. Interference-based Technique
6.3.8. Ellipsometry Technique
6.3.9. Others
6.4. Market Attractiveness Analysis, by Technique
7. Global Label-free Array Systems Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Drug Discovery
7.3.2. Biomolecular Interactions
7.3.3. Detection of Disease Biomarkers
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Label-free Array Systems Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Contract Research Organizations
8.3.2. Academic & Research Institutes
8.3.3. Pharmaceutical & Biotechnology Industries
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Label-free Array Systems Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Label-free Array Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Technique, 2017–2031
10.2.1. Surface Plasmon Resonance
10.2.2. Microcantilever
10.2.3. Scanning Kelvin Nanoprobe
10.2.4. Enthalpy Array
10.2.5. Atomic Force Microscopy
10.2.6. Electrochemical Impedance Spectroscopy
10.2.7. Interference-based Technique
10.2.8. Ellipsometry Technique
10.2.9. Others
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Drug Discovery
10.3.2. Biomolecular Interactions
10.3.3. Detection of Disease Biomarkers
10.3.4. Others
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Contract Research Organizations
10.4.2. Academic & Research Institutes
10.4.3. Pharmaceutical & Biotechnology Industries
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Technique
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Label-free Array Systems Market Analysis and Forecast
11.1. Introduction
11.2. Market Value Forecast, by Technique, 2017–2031
11.2.1. Surface Plasmon Resonance
11.2.2. Microcantilever
11.2.3. Scanning Kelvin Nanoprobe
11.2.4. Enthalpy Array
11.2.5. Atomic Force Microscopy
11.2.6. Electrochemical Impedance Spectroscopy
11.2.7. Interference-based Technique
11.2.8. Ellipsometry Technique
11.2.9. Others
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Drug Discovery
11.3.2. Biomolecular Interactions
11.3.3. Detection of Disease Biomarkers
11.3.4. Others
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Contract Research Organizations
11.4.2. Academic & Research Institutes
11.4.3. Pharmaceutical & Biotechnology Industries
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Technique
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Label-free Array Systems Market Analysis and Forecast
12.1. Introduction
12.2. Market Value Forecast, by Technique, 2017–2031
12.2.1. Surface Plasmon Resonance
12.2.2. Microcantilever
12.2.3. Scanning Kelvin Nanoprobe
12.2.4. Enthalpy Array
12.2.5. Atomic Force Microscopy
12.2.6. Electrochemical Impedance Spectroscopy
12.2.7. Interference-based Technique
12.2.8. Ellipsometry Technique
12.2.9. Others
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Drug Discovery
12.3.2. Biomolecular Interactions
12.3.3. Detection of Disease Biomarkers
12.3.4. Others
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Contract Research Organizations
12.4.2. Academic & Research Institutes
12.4.3. Pharmaceutical & Biotechnology Industries
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Technique
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Label-free Array Systems Market Analysis and Forecast
13.1. Introduction
13.2. Market Value Forecast, by Technique, 2017–2031
13.2.1. Surface Plasmon Resonance
13.2.2. Microcantilever
13.2.3. Scanning Kelvin Nanoprobe
13.2.4. Enthalpy Array
13.2.5. Atomic Force Microscopy
13.2.6. Electrochemical Impedance Spectroscopy
13.2.7. Interference-based Technique
13.2.8. Ellipsometry Technique
13.2.9. Others
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Drug Discovery
13.3.2. Biomolecular Interactions
13.3.3. Detection of Disease Biomarkers
13.3.4. Others
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Contract Research Organizations
13.4.2. Academic & Research Institutes
13.4.3. Pharmaceutical & Biotechnology Industries
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Technique
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Label-free Array Systems Market Analysis and Forecast
14.1. Introduction
14.2. Market Value Forecast, by Technique, 2017–2031
14.2.1. Surface Plasmon Resonance
14.2.2. Microcantilever
14.2.3. Scanning Kelvin Nanoprobe
14.2.4. Enthalpy Array
14.2.5. Atomic Force Microscopy
14.2.6. Electrochemical Impedance Spectroscopy
14.2.7. Interference-based Technique
14.2.8. Ellipsometry Technique
14.2.9. Others
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Drug Discovery
14.3.2. Biomolecular Interactions
14.3.3. Detection of Disease Biomarkers
14.3.4. Others
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Contract Research Organizations
14.4.2. Academic & Research Institutes
14.4.3. Pharmaceutical & Biotechnology Industries
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Technique
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2018)
15.3. Company Profiles
15.3.1. GE Healthcare
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Company Financials
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis
15.3.2. Attana AB
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Company Financials
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. Agilent Technologies, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Company Financials
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Danaher Corporation
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Company Financials
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. F. Hoffmann-La Roche AG
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Company Financials
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Bio-Rad Laboratories
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Company Financials
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. GWC Technologies
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Company Financials
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. PerkinElmer, Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Company Financials
15.3.8.3. Growth Strategies
15.3.8.4. SWOT Analysis
15.3.9. BiOptix, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Company Financials
15.3.9.3. Growth Strategies
15.3.9.4. SWOT Analysis
Table 01: Global Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 02: Global Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Label-free Array Systems Market value (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 06: North America Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 07: North America Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017-2027
Table 08: North America Label-free Array Systems Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 09: Europe Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 10: Europe Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 11: Europe Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 12: Europe Label-free Array Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 13: Asia Pacific Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 14: Asia Pacific Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 15: Asia Pacific Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Label-free Array Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Latin America Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 18: Latin America Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 19: Latin America Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 20: Latin America Label-free Array Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Middle East & Africa Label-free Array Systems Market Value (US$ Mn) Forecast, by Technique, 2017–2031
Table 22: Middle East & Africa Label-free Array Systems Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Middle East & Africa Label-free Array Systems Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 24: Middle East & Africa Label-free Array Systems Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031